KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Merck (MRK) over the last 6 years, with Q3 2025 value amounting to $532.0 million.

  • Merck's Depreciation and Depletion fell 379.75% to $532.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 47.98%. This contributed to the annual value of $2.1 billion for FY2024, which is 1509.85% up from last year.
  • Per Merck's latest filing, its Depreciation and Depletion stood at $532.0 million for Q3 2025, which was down 379.75% from $518.0 million recorded in Q2 2025.
  • In the past 5 years, Merck's Depreciation and Depletion registered a high of $553.0 million during Q3 2024, and its lowest value of $371.0 million during Q2 2021.
  • For the 5-year period, Merck's Depreciation and Depletion averaged around $468.8 million, with its median value being $474.0 million (2022).
  • In the last 5 years, Merck's Depreciation and Depletion surged by 2776.28% in 2022 and then plummeted by 1012.66% in 2023.
  • Merck's Depreciation and Depletion (Quarter) stood at $452.0 million in 2021, then decreased by 4.87% to $430.0 million in 2022, then rose by 16.74% to $502.0 million in 2023, then grew by 3.98% to $522.0 million in 2024, then increased by 1.92% to $532.0 million in 2025.
  • Its last three reported values are $532.0 million in Q3 2025, $518.0 million for Q2 2025, and $502.0 million during Q1 2025.